Impact of membrane lung surface area and blood flow on extracorporeal CO2 removal during severe respiratory acidosis

Abstract Background Veno-venous extracorporeal CO2 removal (vv-ECCO2R) is increasingly being used in the setting of acute respiratory failure. Blood flow rates through the device range from 200 ml/min to more than 1500 ml/min, and the membrane surface areas range from 0.35 to 1.3 m2. The present stu...

Full description

Bibliographic Details
Main Authors: Christian Karagiannidis, Stephan Strassmann, Daniel Brodie, Philine Ritter, Anders Larsson, Ralf Borchardt, Wolfram Windisch
Format: Article
Language:English
Published: SpringerOpen 2017-08-01
Series:Intensive Care Medicine Experimental
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40635-017-0147-0
id doaj-a4ed6403672f4977bf1343b6207d5f1f
record_format Article
spelling doaj-a4ed6403672f4977bf1343b6207d5f1f2020-11-24T21:35:03ZengSpringerOpenIntensive Care Medicine Experimental2197-425X2017-08-015111310.1186/s40635-017-0147-0Impact of membrane lung surface area and blood flow on extracorporeal CO2 removal during severe respiratory acidosisChristian Karagiannidis0Stephan Strassmann1Daniel Brodie2Philine Ritter3Anders Larsson4Ralf Borchardt5Wolfram Windisch6Department of Pneumology and Critical Care Medicine, Cologne-Merheim Hospital, ARDS and ECMO Centre, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University HospitalDepartment of Pneumology and Critical Care Medicine, Cologne-Merheim Hospital, ARDS and ECMO Centre, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University HospitalDivision of Pulmonary, Allergy and Critical Care, Columbia University College of Physicians and Surgeons/New York-Presbyterian HospitalEnmodes GmbHHedenstierna Laboratory, Anesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala UniversityEnmodes GmbHDepartment of Pneumology and Critical Care Medicine, Cologne-Merheim Hospital, ARDS and ECMO Centre, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University HospitalAbstract Background Veno-venous extracorporeal CO2 removal (vv-ECCO2R) is increasingly being used in the setting of acute respiratory failure. Blood flow rates through the device range from 200 ml/min to more than 1500 ml/min, and the membrane surface areas range from 0.35 to 1.3 m2. The present study in an animal model with similar CO2 production as an adult patient was aimed at determining the optimal membrane lung surface area and technical requirements for successful vv-ECCO2R. Methods Four different membrane lungs, with varying lung surface areas of 0.4, 0.8, 1.0, and 1.3m2 were used to perform vv-ECCO2R in seven anesthetized, mechanically ventilated, pigs with experimentally induced severe respiratory acidosis (pH 7.0–7.1) using a 20Fr double-lumen catheter with a sweep gas flow rate of 8 L/min. During each experiment, the blood flow was increased stepwise from 250 to 1000 ml/min. Results Amelioration of severe respiratory acidosis was only feasible when blood flow rates from 750 to 1000 ml/min were used with a membrane lung surface area of at least 0.8 m2. Maximal CO2 elimination was 150.8 ml/min, with pH increasing from 7.01 to 7.30 (blood flow 1000 ml/min; membrane lung 1.3 m2). The membrane lung with a surface of 0.4 m2 allowed a maximum CO2 elimination rate of 71.7 mL/min, which did not result in the normalization of pH, even with a blood flow rate of 1000 ml/min. Also of note, an increase of the surface area above 1.0 m2 did not result in substantially higher CO2 elimination rates. The pressure drop across the oxygenator was considerably lower (<10 mmHg) in the largest membrane lung, whereas the smallest revealed a pressure drop of more than 50 mmHg with 1000 ml blood flow/min. Conclusions In this porcine model, vv-ECCO2R was most effective when using blood flow rates ranging between 750 and 1000 ml/min, with a membrane lung surface of at least 0.8 m2. In contrast, low blood flow rates (250–500 ml/min) were not sufficient to completely correct severe respiratory acidosis, irrespective of the surface area of the membrane lung being used. The converse was also true, low surface membrane lungs (0.4 m2) were not capable of completely correcting severe respiratory acidosis across the range of blood flows used in this study.http://link.springer.com/article/10.1186/s40635-017-0147-0ECMOECCO2RSevere COPDExacerbationAsthmaRenal replacement therapy
collection DOAJ
language English
format Article
sources DOAJ
author Christian Karagiannidis
Stephan Strassmann
Daniel Brodie
Philine Ritter
Anders Larsson
Ralf Borchardt
Wolfram Windisch
spellingShingle Christian Karagiannidis
Stephan Strassmann
Daniel Brodie
Philine Ritter
Anders Larsson
Ralf Borchardt
Wolfram Windisch
Impact of membrane lung surface area and blood flow on extracorporeal CO2 removal during severe respiratory acidosis
Intensive Care Medicine Experimental
ECMO
ECCO2R
Severe COPD
Exacerbation
Asthma
Renal replacement therapy
author_facet Christian Karagiannidis
Stephan Strassmann
Daniel Brodie
Philine Ritter
Anders Larsson
Ralf Borchardt
Wolfram Windisch
author_sort Christian Karagiannidis
title Impact of membrane lung surface area and blood flow on extracorporeal CO2 removal during severe respiratory acidosis
title_short Impact of membrane lung surface area and blood flow on extracorporeal CO2 removal during severe respiratory acidosis
title_full Impact of membrane lung surface area and blood flow on extracorporeal CO2 removal during severe respiratory acidosis
title_fullStr Impact of membrane lung surface area and blood flow on extracorporeal CO2 removal during severe respiratory acidosis
title_full_unstemmed Impact of membrane lung surface area and blood flow on extracorporeal CO2 removal during severe respiratory acidosis
title_sort impact of membrane lung surface area and blood flow on extracorporeal co2 removal during severe respiratory acidosis
publisher SpringerOpen
series Intensive Care Medicine Experimental
issn 2197-425X
publishDate 2017-08-01
description Abstract Background Veno-venous extracorporeal CO2 removal (vv-ECCO2R) is increasingly being used in the setting of acute respiratory failure. Blood flow rates through the device range from 200 ml/min to more than 1500 ml/min, and the membrane surface areas range from 0.35 to 1.3 m2. The present study in an animal model with similar CO2 production as an adult patient was aimed at determining the optimal membrane lung surface area and technical requirements for successful vv-ECCO2R. Methods Four different membrane lungs, with varying lung surface areas of 0.4, 0.8, 1.0, and 1.3m2 were used to perform vv-ECCO2R in seven anesthetized, mechanically ventilated, pigs with experimentally induced severe respiratory acidosis (pH 7.0–7.1) using a 20Fr double-lumen catheter with a sweep gas flow rate of 8 L/min. During each experiment, the blood flow was increased stepwise from 250 to 1000 ml/min. Results Amelioration of severe respiratory acidosis was only feasible when blood flow rates from 750 to 1000 ml/min were used with a membrane lung surface area of at least 0.8 m2. Maximal CO2 elimination was 150.8 ml/min, with pH increasing from 7.01 to 7.30 (blood flow 1000 ml/min; membrane lung 1.3 m2). The membrane lung with a surface of 0.4 m2 allowed a maximum CO2 elimination rate of 71.7 mL/min, which did not result in the normalization of pH, even with a blood flow rate of 1000 ml/min. Also of note, an increase of the surface area above 1.0 m2 did not result in substantially higher CO2 elimination rates. The pressure drop across the oxygenator was considerably lower (<10 mmHg) in the largest membrane lung, whereas the smallest revealed a pressure drop of more than 50 mmHg with 1000 ml blood flow/min. Conclusions In this porcine model, vv-ECCO2R was most effective when using blood flow rates ranging between 750 and 1000 ml/min, with a membrane lung surface of at least 0.8 m2. In contrast, low blood flow rates (250–500 ml/min) were not sufficient to completely correct severe respiratory acidosis, irrespective of the surface area of the membrane lung being used. The converse was also true, low surface membrane lungs (0.4 m2) were not capable of completely correcting severe respiratory acidosis across the range of blood flows used in this study.
topic ECMO
ECCO2R
Severe COPD
Exacerbation
Asthma
Renal replacement therapy
url http://link.springer.com/article/10.1186/s40635-017-0147-0
work_keys_str_mv AT christiankaragiannidis impactofmembranelungsurfaceareaandbloodflowonextracorporealco2removalduringsevererespiratoryacidosis
AT stephanstrassmann impactofmembranelungsurfaceareaandbloodflowonextracorporealco2removalduringsevererespiratoryacidosis
AT danielbrodie impactofmembranelungsurfaceareaandbloodflowonextracorporealco2removalduringsevererespiratoryacidosis
AT philineritter impactofmembranelungsurfaceareaandbloodflowonextracorporealco2removalduringsevererespiratoryacidosis
AT anderslarsson impactofmembranelungsurfaceareaandbloodflowonextracorporealco2removalduringsevererespiratoryacidosis
AT ralfborchardt impactofmembranelungsurfaceareaandbloodflowonextracorporealco2removalduringsevererespiratoryacidosis
AT wolframwindisch impactofmembranelungsurfaceareaandbloodflowonextracorporealco2removalduringsevererespiratoryacidosis
_version_ 1725946838892150784